Age-dependent variation of T1 and T2 relaxation times of adenocarcinoma in mice.
- 1 August 1987
- journal article
- research article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 164 (2) , 543-548
- https://doi.org/10.1148/radiology.164.2.3602399
Abstract
The T1 and T2 values of adenocarcinoma EO 771 inoculated into the hind leg of mice are characterized and correlated with the histopathologic state of the tumor. Growth-dependent changes (indicated by a T1 of 630-910 msec and a T2 of 68-185 msec) can be separated into four characteristic phases. The increase in relaxation times in the early phases (A and B) is due to an increasing amount of viable tumor tissue relative to normal muscle tissue. In the later phases (C and D), a decline of the relaxation parameters is observed that is parallel to an increase in the fraction of necrotic tissue. By multiexponential analysis, two relaxation components (indicated by and, respectively) for T1 and T2 and the corresponding fractions alpha 1 and alpha 2 can be observed for both tumor and surrounding muscle tissue. A tissue criterion ("magnetic resonance fingerprint") is defined by a combination of these multiple parameters. This criterion allows separation of not only muscle and tumor tissue but also viable (early state) and necrotic (late state) tumor tissue.This publication has 5 references indexed in Scilit:
- In vitroprotonT1andT2studies on rat liver: Analysis of multiexponential relaxation processesMagnetic Resonance in Medicine, 1986
- Proton spin-lattice relaxation studies of tissue response to radiotherapy in micePhysics in Medicine & Biology, 1983
- CELL LOSS FROM VIABLE AND NECROTIC TUMOR REGIONS MEASURED BY I-125-UDR1983
- Nuclear Magnetic Resonance Relaxation and Water Contents in Normal Mouse and Rat Tissues and in Cancer Cells23JNCI Journal of the National Cancer Institute, 1980
- Studies in a tumor spectrum.I. Comparison of the action of methylbis(2-chloroethyl)amine and 3-bis(2-chloroethyl)aminomethyl-4-methoxymethyl-5-hydroxy-6-methylpyridine on the growth of a variety of mouse and rat tumorsCancer, 1952